Oxaliplatin Recruiting Phase 2 Trials for Malignant Digestive System Neoplasm Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT038006932 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers